Combination therapies for the treatment of breast cancer
US11083722B2 · kind B2 · utility
0Cited by
5References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 16, 2018 |
| Grant date | Aug 10, 2021 |
| Priority date | — |
| Expiry date | Jul 7, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein is a combination therapy useful for the treatment breast cancer. The combination comprises an ER-alpha inhibitor and a CDK 4/6 inhibitor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.